Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026Unusual Whales·6 hours agoTNXP+4.71%
Tonix Pharmaceuticals publishes investor deck highlighting TONMYA fibromyalgia launch strategyPUBT·Jul 20 at 06:17 AMTNXP+4.71%
Tonix Pharmaceuticals investor deck spotlights TONMYA fibromyalgia launch and late-stage pipeline plansPUBT·Jul 16 at 01:17 PMTNXP+4.71%
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal ModelsUnusual Whales·Jul 15 at 08:06 AMTNXP+4.71%
Tonix Pharma signs managed Medicare payer deal adding 9 million TONMYA-covered lives effective Jan. 1, 2027PUBT·Jul 13 at 06:01 AMTNXP+4.71%
Tonix Pharmaceuticals posts investor deck spotlighting TONMYA fibromyalgia launch strategyPUBT·Jul 7 at 04:02 PMTNXP+4.71%
